Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

NTEC - Intec Parent Inc

Previous close
9.63
0   0%

Share volume: 0
Last Updated: Tue 03 Aug 2021 06:00:00 AM CEST
Pharmaceutical Preparation Manufacturing : -2.88%

PREVIOUS CLOSE
CHG
CHG%
$9.63
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
28%
Profitability 25%
Dept financing 9%
Liquidity 28%
Performance 35%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
6.41%
1 Month
-31.02%
3 Months
-37.63%
6 Months
-48.00%
1 Year
-70.91%
2 Year
-76.28%
Key data
Stock price
$9.63
P/E Ratio 
0.00
DAY RANGE
$9.59 - $11.10
EPS 
$0.00
52 WEEK RANGE
$8.80 - $36.80
52 WEEK CHANGE
-$0.72
MARKET CAP 
70.982 M
YIELD 
N/A
SHARES OUTSTANDING 
7.371 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
1.17
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$5,618,437
AVERAGE 30 VOLUME 
$2,095,733
Company detail
CEO: Jeffrey Meckler
Region: US
Website: intecpharma.com
Employees: 40
IPO year: -
Issue type: Common Stock
Market: NASDAQ
Industry: Pharmaceutical Preparation Manufacturing
Sector: Manufacturing

Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The Company's Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and specific release mechanism.

Recent news